NDC11 00067200091
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00067-2000-91 | 00067-2000 |
| 0067-2000-91 | 0067-2000 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 0067-2000 | 0067-2000-91 | I | Inactivated by FDA | excluded / ndc_excluded.zip | fb8cb913e6d1… | eb8c232b6be0… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Excedrin PM Triple Action Caplets and Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, AND DIPHENHYDRAMINE CITRATE | Haleon US Holdings LLC | 444fa225-c204-45d1-b3b3-aa5650ee5d07 | 2026-02-23 | Warnings | 0067-2000-91 00067200091 |
| Excedrin Extra Strength and Excedrin Tension Headache | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 2c8df1c7-7864-48df-939c-d9ae22e0f52c | 2026-02-23 | Warnings | 0067-2000-91 00067200091 |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | a71074a6-cc19-4bb3-8c84-4e82a8906801 | 2024-04-22 | Warnings | 0067-2000-91 0067-2000 00067200091 |